Rheumatoid Arthritis

COVID-19 has raised additional concerns for rheumatologists, especially regarding health care for patients with rheumatic diseases.

Janet Pope, MD, MPH, explains her treatment strategies for unresponsive patients with rheumatoid arthritis as well as clinical pearls of 2021.

Many rheumatoid arthritis (RA) patients experience lung manifestations such as interstitial lung disease, but what are the implications and who is most at risk? Test your knowledge with this quiz.

Rheumatoid arthritis is known risk factor for cardiovascular disease, but how much do you know about the association? Test your knowledge with this quiz.

Pri-Med West presenter, Dr. Peng Thim Fan asks the questions that many rheumatologists have likely been contemplating now that disease treatment is so successful.

The American College of Rheumatology recommends that a treat-to-target strategy is followed for rheumatoid arthritis. Test your knowledge of how to maximize the potential benefits of this approach with this quiz.

Approximately a quarter of RAPID3 assessments, confirmed with 92% accuracy by DAS28 scores, reported patients had low disease activity and could, therefore, postpone routine clinical visits.

Mental and physical illnesses, such as rheumatoid arthritis, are often driven by social, environmental, and economic factors and may affect disease outcomes.

COVID-19 vaccines and drugs for rheumatoid arthritis (RA) don’t always mix well. How much do you know about how RA medications impact the immune response generated by COVID-19 vaccines?

White a treat-to-target strategy is an important part of managing patients with rheumatoid arthritis, a more controlled implementation with closer follow-up appointments and patient education yielded better outcomes.

Health-related quality of life and treatment satisfaction are often used to improve treatment outcomes as well as clinical care.

“There are no tailored age-specific treatment guidelines, and older adults are less likely to receive aggressive therapy for reasons of polypharmacy and multimorbidity,” investigators stated.

At the outset of the COVID-19 pandemic, there were concerns that patients with rheumatoid arthritis would be more vulnerable due to their condition and its treatment. What impact has the availability of vaccines against COVID-19 had on the vulnerability of patients with rheumatoid arthritis? Test your knowledge with this quiz.

“These data suggest that vaccine responses are reduced but can be improved by sufficient vaccine/virus exposure,” investigators stated.

Patients with rheumatoid arthritis are at greater risk of cardiovascular disease, but how much do you know about the use of statins in these patients to reduce their risk of cardiovascular morbidity and mortality? Test your knowledge with this quiz.

Influenza vaccination rates remain low within patients with rheumatoid arthritis. Investigators urge rheumatologists to encourage vaccination acceptance as a part of routine care.

“[Some] Patients may benefit from switching to a fully human biologic, such as IV-golimumab, to control disease activity/improve drug tolerance," investigators stated.

Authors call for further investigation of pathophysiological pathways between rheumatoid arthritis and primary open-angle glaucoma.

Limited physical function, fatigue, mental health issues (resulting from chronic disease), and medication issues can further affect the ability of children with rheumatic disease from performing well in school.

Recent studies suggest that a gap in cardiovascular risk remains between patients with rheumatoid arthritis and the general population.

Treat-to-target is a key strategy used in the treatment of many chronic conditions. Test your knowledge of its use in rheumatoid arthritis.

Methotrexate is the first-line treatment for rheumatoid arthritis. As with all drugs, there is a risk of experiencing adverse effects. Do you know what type of adverse effects are most likely with methotrexate and who is likely to experience them? Take this quiz to find out.

Roy Fleischmann, MD, explains the history of biosimilars in rheumatology as well as implementing biosimilars in the United States.

When patients undergo surgery for hip and knee replacements, adjustment to their rheumatoid arthritis care may be required. Test your knowledge of how to manage patients undergoing these types of surgery in this quiz.

In rheumatoid arthritis, a treat-to-target approach aims for remission or low disease activity within the first 3 months. However, investigators noted that improvements continued to increase throughout the 52-week period.